BioAge Labs, Inc.
BIOA
$4.51
-$0.10-2.17%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 66.23% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 66.23% | -- | |||
| Cost of Revenue | 78.63% | -- | |||
| Gross Profit | -80.49% | -- | |||
| SG&A Expenses | 8.12% | 10.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 51.89% | -29.43% | |||
| Operating Income | -50.62% | 35.15% | |||
| Income Before Tax | -66.79% | 38.81% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -66.79% | 38.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -66.79% | 38.81% | |||
| EBIT | -50.62% | 35.15% | |||
| EBITDA | -50.61% | 35.18% | |||
| EPS Basic | -66.81% | 38.54% | |||
| Normalized Basic EPS | -66.77% | 38.73% | |||
| EPS Diluted | -66.81% | 38.54% | |||
| Normalized Diluted EPS | -66.77% | 38.73% | |||
| Average Basic Shares Outstanding | 0.00% | -0.46% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||